SavedAdd your journal

Journals / Anadolu Kardiyoloji Dergisi / 2006 / Cilt: 6 - Sayı: 2

Önceden geçirilmiş perkütan koroner girişim cerrahi revaskülarizasyon sonrası semptom rekürrensini ve majör kardiyak olayları artırabilir mi?

Previous percutaneous coronary intervention may increase symptom recurrence and adverse cardiac events following surgical revascularization

Aydın AYTAÇ
Ahmet ŞAŞMAZEL
Ahmet Tayfun GÜRBÜZ
Ayhan A. ZİA
Haiyan CUI
Pages
148–152
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Methods: Overall 611 patients who survived 30 days after coronary artery bypass graft surgery (CABG) between 2001 and 2005 were evaluated.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:bjective: The number of percutaneous coronary interventions (PCI) is increasing.
📊
Key Findings & Data:Methods: Overall 611 patients who survived 30 days after coronary artery bypass graft surgery (CABG) between 2001 and 2005 were evaluated.
💡
Conclusion & Impact:Results: Preoperative PCI was an independent risk factor for symptom recurrence (p
🔬Design:Research Article
📍Scope:2001 Verileri
⚙️Variables:Domain Parameters

Abstract

bjective: The number of percutaneous coronary interventions (PCI) is increasing. There is limited outcome data on patients with a history of PCI and subsequently required surgical revascularization. Methods: Overall 611 patients who survived 30 days after coronary artery bypass graft surgery (CABG) between 2001 and 2005 were evaluated. Mean follow-up was 29.4 ± 11.3 months and 45% were female. The effect of preoperative PCI as a risk factor for symptom recurrence and adverse cardiovascular events and mortality was determined. Results: Preoperative PCI was an independent risk factor for symptom recurrence (p

Özet

Amaç: Perkütan koroner arter girişimlerin sayısı gün geçtikçe artmaktadır. Perkütan koroner arter girişimi yapılıp da daha sonra cerrahi revaskülarizasyon yapılan hastaların ilerideki sonuçları hakkında çok az bilgi mevcuttur. Yöntemler: İki bin bir ile 2005 yılları arasında koroner arter baypas ameliyatı olan ve 30 gün hayatta kalan 611 hasta incelendi. Ortalama takip süresi 29.4 ± 11.3 ay idi ve hastaların % 45'i bayandı. Preoperatif perkütan koroner girişimin semptom rekürrensi, majör kardiyak olaylar ve mortalite üzerindeki etkisi incelendi. Bulgular: Preoperatif perkütan koroner girişim semptom rekürrensini (p

🔖

Cite This Article

AYTAÇ, A., ŞAŞMAZEL, A., GÜRBÜZ, A. T., ZİA, A. A., CUI, H. (2022). Önceden geçirilmiş perkütan koroner girişim cerrahi revaskülarizasyon sonrası semptom rekürrensini ve majör kardiyak olayları artırabilir mi?. Anadolu Kardiyoloji Dergisi, Cilt: 6 - Sayı: 2, 148–152. https://ajindex.com/articles/437289

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Anderson HV, Shaw RE, Brindis RG, Hewitt K, Krone RJ, Block PC, et al. A contemporary overview of percutaneous coronary interventions. The American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR). J Am Coll Cardiol 2002; 39: 1096-103
  2. Cohen DJ, Houser F, Mack M, Simon AW, Battaglia SL, Tarkington LG, et al. Practice and outcomes of percutaneous coronary intervention in the community before drug-eluting stents: a report from the HCA database. J Invasive Cardiol 2003; 15: 121-7
  3. Yock CA, Yock PG. The drug-eluting stent information gap. Am Heart Hosp J 2004; 2: 21-5
  4. Wu AH, Goss JR, Maynard C, Stewart DK, Zhao XQ. Predictors of repeat revascularization after nonemergent, first percutaneous coronary intervention in the community. Am Heart J 2004; 147: 146-50. 5. van den Brand MJ, Rensing BJ, Morel MA, Foley DP, de Valk V, Breeman A, et al. The effect of completeness of revascularization on event-free survival at one year in the ARTS trial. J Am Coll Cardiol 2002; 39: 559-64
  5. Casey C, Faxon D. Multivessel coronary disease and percutaneous coronary intervention. Heart 2004; 90: 341-6
  6. Singh M, Gersh BJ, McClelland RL, Ho KK, Willerson JT, Penny WF, et al. Clinical and angiographic predictors of restenosis after percutaneous coronary intervention: insights from the Prevention of Restenosis With Tranilast and Its Outcomes (PRESTO) trial. Circulation 2004; 109: 2727-31
  7. Mittal S, Weiss DL, Hirshfeld JW Jr, Kolansky DM, Herrmann HC. Comparison of outcome after stenting for de novo versus restenotic narrowings in native coronary arteries. Am J Cardiol 1997; 80: 711-5
  8. Suresh CG, Grant SC, Henderson RA, Bennett DH. Late symptom recurrence after successful coronary angioplasty: angiographic outcome. Int J Cardiol 1993; 31; 42: 257-62
  9. Alderman EL, Kip KE, Whitlow PL, Bashore T, Fortin D, Bourassa MG, et al. Bypass Angioplasty Revascularization Investigation. Native coronary disease progression exceeds failed revascularization as cause of angina after five years in the Bypass Angioplasty Revascularization Investigation (BARI). J Am Coll Cardiol 2004; 44: 766-74
  10. Zellweger MJ, Weinbacher M, Zutter AW, Jeger RV, Mueller-Brand J, Kaiser C, et al. Long-term outcome of patients with silent versus symptomatic ischemia six months after percutaneous coronary intervention and stenting. J Am Coll Cardiol 2003; 42: 33-40
  11. Kastrati A, Schomig A, Elezi S, Schuhlen H, Wilhelm M, Dirschinger J. Interlesion dependence of the ri